ciprofloxacin has been researched along with Melanoma in 4 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Melanoma: A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The obtained results for COLO829 melanoma cells were compared with data for normal dark pigmented melanocytes and the use of ciprofloxacin as a potential anticancer drug for the treatment of melanoma in vivo was considered." | 7.88 | Ciprofloxacin-mediated induction of S-phase cell cycle arrest and apoptosis in COLO829 melanoma cells. ( Beberok, A; Buszman, E; Delijewski, M; Minecka, A; Respondek, M; Rok, J; Rzepka, Z; Wrześniok, D, 2018) |
| "The obtained results for COLO829 melanoma cells were compared with data for normal dark pigmented melanocytes and the use of ciprofloxacin as a potential anticancer drug for the treatment of melanoma in vivo was considered." | 3.88 | Ciprofloxacin-mediated induction of S-phase cell cycle arrest and apoptosis in COLO829 melanoma cells. ( Beberok, A; Buszman, E; Delijewski, M; Minecka, A; Respondek, M; Rok, J; Rzepka, Z; Wrześniok, D, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beberok, A | 1 |
| Wrześniok, D | 1 |
| Minecka, A | 1 |
| Rok, J | 1 |
| Delijewski, M | 1 |
| Rzepka, Z | 1 |
| Respondek, M | 1 |
| Buszman, E | 1 |
| Aldaghi, SA | 1 |
| Jalal, R | 1 |
| dos Santos, VM | 1 |
| Passini, VV | 1 |
| Gebrim, DG | 1 |
| Flores, LP | 1 |
| Silva, RF | 1 |
| da Cruz Silva, SA | 1 |
| Montgomery, JP | 1 |
| Patterson, PH | 1 |
4 other studies available for ciprofloxacin and Melanoma
| Article | Year |
|---|---|
Ciprofloxacin-mediated induction of S-phase cell cycle arrest and apoptosis in COLO829 melanoma cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Ciprofloxacin; Dose-Response Rela | 2018 |
Concentration-Dependent Dual Effects of Ciprofloxacin on SB-590885-Resistant BRAF
Topics: Antineoplastic Agents; Cell Movement; Cell Proliferation; Cell Survival; Ciprofloxacin; Dose-Respons | 2019 |
Paravertebral abscess by Escherichia coli and melanoma metastasis in an older woman.
Topics: Abscess; Aged, 80 and over; Anti-Bacterial Agents; Body Mass Index; Ciprofloxacin; Diabetes Mellitus | 2015 |
Endothelin receptor B antagonists decrease glioma cell viability independently of their cognate receptor.
Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Ciprofloxacin; DNA Damag | 2008 |